BioMarin Pharmaceutical I...
63.78
-3.21 (-4.79%)
At close: Jan 14, 2025, 3:59 PM
63.81
0.05%
After-hours Jan 14, 2025, 04:00 PM EST

BioMarin Pharmaceutical Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Product Revenue 733.87M 702.13M 637.82M 633.15M 568.27M 584.70M 586.43M 525.49M 493.35M 517.66M 505.52M 435.22M 393.84M 486.67M 18.26M 437.05M 16.04M 10.45M 489.04M 436.58M 450.90M 379.07M 394.48M 6.06M 386.32M 367.79M
Product Revenue Growth +4.52% +10.08% +0.74% +11.42% -2.81% -0.29% +11.60% +6.52% -4.70% +2.40% +16.15% +10.51% -19.07% +2565.08% -95.82% +2624.21% +53.48% -97.86% +12.02% -3.17% +18.95% -3.91% +6406.40% -98.43% +5.04% n/a
Royalty And Other Revenue 11.87M 9.90M 11.02M 13.06M 13.06M 10.58M 9.99M 12.05M 12.00M 16.14M 13.83M 14.59M 14.90M 15.02M n/a 15.07M n/a n/a 13.03M 17.86M n/a n/a n/a n/a n/a n/a
Royalty And Other Revenue Growth +19.93% -10.15% -15.63% -0.03% +23.50% +5.89% -17.08% +0.42% -25.67% +16.65% -5.19% -2.09% -0.81% n/a n/a n/a n/a n/a -27.06% n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014
Europe Revenue 518.47M 509.19M 436.43M 301.49M 252.63M 178.75M 139.94M
Europe Revenue Growth +1.82% +16.67% +44.76% +19.34% +41.34% +27.73% n/a
Latin America Revenue 205.86M 218.79M 185.05M 182.44M 147.47M 142.31M 118.56M
Latin America Revenue Growth -5.91% +18.24% +1.43% +23.71% +3.63% +20.03% n/a
Rest Of World Revenue 223.75M 197.63M 172.94M 241.48M 209.21M 124.77M 112.49M
Rest Of World Revenue Growth +13.22% +14.28% -28.38% +15.42% +67.68% +10.91% n/a
United States Revenue 912.38M 778.44M 696.79M 588.24M 507.54M n/a n/a
United States Revenue Growth +17.21% +11.72% +18.45% +15.90% n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 253.48M 276.65M 222.51M 275.02M 231.40M 216.78M 218.38M 245.74M 216.82M 196.84M 194.62M 217.56M 183.33M 184.16M 174.32M 195.51M 179.45M 175.41M 187.29M 187.90M 170.11M 160.75M 162.16M 164.17M 148.57M 153.28M 138.34M 160.28M 130.53M 143.50M 120.02M 142.96M 118.76M 109.58M 105.30M 113.91M 94.04M 101.51M 92.81M
Selling, General, and Administrative Revenue Growth -8.38% +24.34% -19.10% +18.85% +6.74% -0.73% -11.13% +13.34% +10.15% +1.14% -10.55% +18.67% -0.45% +5.65% -10.84% +8.95% +2.30% -6.34% -0.32% +10.46% +5.82% -0.87% -1.23% +10.50% -3.08% +10.80% -13.69% +22.79% -9.04% +19.57% -16.05% +20.38% +8.38% +4.06% -7.56% +21.12% -7.36% +9.38% n/a
Research and Development Revenue 184.90M 183.79M 204.99M 206.25M 191.31M 177.36M 171.85M 172.75M 157.83M 158.19M 160.84M 161.09M 157.87M 161.11M 148.72M 156.67M 147.05M 182.14M 142.26M 172.81M 172.96M 185.64M 183.59M 175.39M 161.41M 175.58M 183.95M 168.61M 154.10M 143.04M 145.00M 175.24M 160.83M 167.04M 158.79M 176.12M 158.71M 157.90M 142.07M
Research and Development Revenue Growth +0.61% -10.34% -0.61% +7.81% +7.87% +3.21% -0.52% +9.45% -0.23% -1.65% -0.16% +2.04% -2.01% +8.33% -5.07% +6.54% -19.26% +28.04% -17.68% -0.09% -6.83% +1.12% +4.68% +8.66% -8.07% -4.55% +9.10% +9.41% +7.73% -1.35% -17.26% +8.96% -3.72% +5.19% -9.84% +10.97% +0.51% +11.14% n/a
Sales and Marketing Revenue 108.90M 122.80M n/a 133.20M 121.90M 115.60M 117.70M 124.60M 111.30M 109.40M 104.90M 113.10M 97.00M 100.90M 94.20M n/a n/a 97.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a -67.00M 67.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth -11.32% n/a -100.00% +9.27% +5.45% -1.78% -5.54% +11.95% +1.74% +4.29% -7.25% +16.60% -3.87% +7.11% n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a -100.00% -200.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a